Teva Pharmaceutical Industries (TEVJF) Net Margin (2016 - 2026)
Teva Pharmaceutical Industries (TEVJF) recorded quarterly Net Margin of 9.19% in Q1 2026, down 7.08% on a QoQ basis from 9.89% in Q4 2025, and up 372.0% year-over-year from 1.95% in Q1 2025.
Teva Pharmaceutical Industries (TEVJF) Net Margin (2016 - 2026) Analysis & Trends
Teva Pharmaceutical Industries has disclosed Net Margin across 11 years of filings, most recently posting 9.19% for Q1 2026.
- Quarterly Net Margin rose 372.0% year-over-year to 9.19% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.84% (up 2102.0% YoY) and the FY2025 annual result came in at 8.11%, up 2000.0% from the prior year.
- Net Margin retreated to 9.19% in Q1 2026, from 9.89% in the prior quarter.
- Over five years, Net Margin peaked at 9.89% in Q4 2025 and troughed at 54.79% in Q4 2022.
- A 5-year average of 14.28% and a median of 13.14% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin sank 2917 bps — and 2023, when it surged 5133 bps.
- Tracing TEVJF's Net Margin over 5 years: stood at 54.79% in 2022, then surged by 94 bps to 3.46% in 2023, then slumped by 181 bps to 9.72% in 2024, then jumped by 202 bps to 9.89% in 2025, then declined by 7 bps to 9.19% in 2026.
- Business Quant data shows TEVJF's Net Margin at 9.19% in Q1 2026, 9.89% in Q4 2025, and 9.55% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Teva Pharmaceutical Industries | - | - | 1.97 Bn | 9.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.19% |
| Dec 31, 2025 | 9.89% |
| Sep 30, 2025 | 9.55% |
| Jun 30, 2025 | 6.56% |
| Mar 31, 2025 | 5.47% |
| Dec 31, 2024 | -9.72% |
| Sep 30, 2024 | -16.44% |
| Jun 30, 2024 | -25.94% |
| Mar 31, 2024 | 6.65% |
| Dec 31, 2023 | -3.46% |
| Sep 30, 2023 | -13.14% |
| Jun 30, 2023 | -40.30% |
| Mar 31, 2023 | -27.42% |
| Dec 31, 2022 | -54.79% |
| Sep 30, 2022 | -19.11% |
| Jun 30, 2022 | -28.24% |
| Mar 31, 2022 | -51.60% |
| Dec 31, 2021 | -27.24% |
| Sep 30, 2021 | -17.44% |
| Jun 30, 2021 | -19.87% |